TI
TXG icon

Trexquant Investment’s 10x Genomics TXG Stock Holding History

Trexquant Investment’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Sell
274,176
-259,112
-49% -$6.79M 0.06% 412
2026
Q1 		$11.3M Sell
533,288
-219,346
-29% -$4.38M 0.08% 338
2025
Q4 		$12.3M Sell
752,634
-281,610
-27% -$4.25M 0.11% 254
2025
Q3 		$12.1M Sell
1,034,244
-494,147
-32% -$6.44M 0.12% 205
2025
Q2 		$17.7M Buy
1,528,391
+388,103
+34% +$3.54M 0.2% 113
2025
Q1 		$9.95M Buy
1,140,288
+545,677
+92% +$6.88M 0.12% 251
2024
Q4 		$8.54M Buy
594,611
+393,854
+196% +$6.22M 0.1% 324
2024
Q3 		$4.53M Sell
200,757
-128,167
-39% -$2.65M 0.06% 514
2024
Q2 		$6.4M Sell
328,924
-33,495
-9% -$877K 0.1% 330
2024
Q1 		$13.6M Buy
362,419
+261,075
+258% +$11.5M 0.27% 64
2023
Q4 		$5.67M Sell
101,344
-381
-0.4% -$16.6K 0.13% 214
2023
Q3 		$4.2M Buy
101,725
+38,538
+61% +$2M 0.11% 269
2023
Q2 		$3.53M Buy
63,187
+19,501
+45% +$1.06M 0.09% 306
2023
Q1 		$2.44M Sell
43,686
-140,898
-76% -$6.58M 0.07% 392
2022
Q4 		$6.73M Buy
184,584
+112,834
+157% +$3.69M 0.19% 135
2022
Q3 		$2.04M Buy
71,750
+63,390
+758% +$2.42M 0.07% 353
2022
Q2 		$378K Sell
8,360
-10,717
-56% -$556K 0.02% 997
2022
Q1 		$1.45M Buy
19,077
+135
+0.7% +$11.8K 0.07% 360
2021
Q4 		$2.82M Buy
+18,942
New +$2.9M 0.17% 141
2021
Q3 		– Sell
-2,107
Closed -$413K – 1504
2021
Q2 		$413K Buy
+2,107
New +$381K 0.03% 576
2021
Q1 		– Sell
-22,729
Closed -$3.22M – 1478
2020
Q4 		$3.22M Buy
22,729
+12,359
+119% +$1.79M 0.34% 71
2020
Q3 		$1.29M Buy
10,370
+4,965
+92% +$521K 0.08% 330
2020
Q2 		$483K Buy
+5,405
New +$421K 0.03% 686

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's TXG Position: Q2 2026 in Review

Trexquant Investment reduced its 10x Genomics (TXG) stake by 49% in Q2 2026, selling an estimated $6.79M and leaving 274,176 shares worth $10.5M. The position accounts for 0.06% of the portfolio, ranked #412.

Trexquant Investment first reported a position in TXG in Q2 2020 and has held it in 23 quarters since. The position peaked at $17.7M in Q2 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Trexquant Investment held 274,176 shares of 10x Genomics worth $10.5M as of Q2 2026.
  • Trexquant Investment sold 259,112 10x Genomics shares in Q2 2026, an estimated $6.79M.
  • 10x Genomics made up 0.06% of Trexquant Investment's portfolio in Q2 2026, its #412 holding.
  • Trexquant Investment first reported a position in 10x Genomics in Q2 2020 and has held it in 23 quarters since.
  • Trexquant Investment's 10x Genomics position peaked at $17.7M in Q2 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.